Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Empros Pharma

Empros Pharma?uq=WouuG6Ev
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a pharmaceutical treatment against overweight and obesity created to address the medical need of obese patients. The company's oral drug EMP16, delays normal food digestion and absorption processes towards the end of the small intestine thereby support and increase the natural satiety response present in the gastrointestinal system to regulate food intake, enabling patients to enhances the entire endogenous hormone response in a physiological way.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Fogdevreten 2
  • 171 65 Stockholm
  • Sweden

+46 070-723 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Empros Pharma’s full profile, request a free trial.

Empros Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Jan-2017 Completed Clinical Trials - Phase 2
2. Early Stage VC 01-Jan-2016 Completed Clinical Trials - General
1. Buyout/LBO Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Empros Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Flerie Invest Venture Capital Majority 000 0000 000000 0

Empros Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
Arvid Söderhäll Ph.D Chief Executive Officer
Hans Lennernäs Ph.D Chief Scientific Officer, Board Member and Co-Founder
Göran Alderborn Ph.D Scientific Advisor & Co-Founder
Ulf Holmbäck Ph.D Head of Clinical Program, Board Member and Co-Founder
Anders Forslund MD Chief Medical Officer, Board Member and Co-Founder

Empros Pharma Board Members (6)

Name Representing Role Since Contact
Info
Anders Forslund MD Empros Pharma Chief Medical Officer, Board Member and Co-Founder 000 0000
Carl-Johan Spak Ph.D Self Board Member 000 0000
Hans Lennernäs Ph.D Empros Pharma Chief Scientific Officer, Board Member and Co-Founder 000 0000
Lars Martin Self Chairman 000 0000
Thomas Eldered Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »